iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership95,031 shares
Latest Disclosed Value $ 16,054,049
Advisor Group Holdings, Inc. reports 2.29% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 95,031 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $16,054,049 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 92,901 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 2.29% during the quarter. The current value of the position is $12,453,813 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 95,031 2,130 2.29 16,054 2.32 0.0137
2026-02-17 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 92,901 -3,162 -3.29 15,691 16.52 0.0229
2025-11-14 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 96,063 5,061 5.56 13,466 16.89 0.0188
2025-09-04 2025-06-30 13F/A-1 SHARES TR ISHARES BIOTECH 464287556 91,002 -334 -0.37 11,520 -1.45 0.0205
2025-08-13 2025-06-30 13F SHARES TR ISHARES BIOTECH 464287556 86,628 -4,708 11,416 0.0132
2025-05-12 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 91,336 -14,329 -13.56 11,689 -16.36 0.0260
2025-06-06 2024-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 105,665 -673 -0.63 13,977 -9.77 0.0314
2025-02-07 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 93,244 -13,094 13,226 0.0337
2024-11-13 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 106,338 -11,991 -10.13 15,489 -4.67 0.0349
2024-08-13 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 118,329 -41,844 -26.12 16,248 -26.10 0.0384
2024-05-10 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 160,173 13,777 9.41 21,985 10.52 0.0491
2024-02-12 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 146,396 -61,540 -29.60 19,893 -21.78 0.0348
2023-11-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 207,936 34,089 19.61 25,433 15.21 0.0376
2023-08-21 2023-06-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 173,847 9,757 5.95 22,076 4.12 0.0396
2023-08-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 212,517 48,427 22,037 0.0060
2023-05-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 164,090 -132,965 -44.76 21,202 -45.64 0.0399
2023-02-10 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 297,055 123,753 71.41 39,006 92.42 0.0790
2022-11-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 173,302 -4,699 -2.64 20,271 -3.29 0.0463
2022-08-10 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 178,001 -32,007 -15.24 20,961 -25.86 0.0462
2022-05-04 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 210,008 -52,591 -20.03 28,273 -29.46 0.0549
2022-02-03 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 262,599 39,121 17.51 40,080 10.95 0.0759
2021-11-05 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 223,478 -13,299 -5.62 36,125 -6.80 0.0753
2021-08-02 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 236,777 -38,873 -14.10 38,761 -6.63 0.0839
2021-05-13 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 275,650 27,821 11.23 41,512 10.56 0.0999
2021-02-10 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 247,829 -3,066 -1.22 37,547 10.50 0.1003
2020-11-12 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 250,895 20,766 9.02 33,978 8.01 0.1016
2020-08-14 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 230,129 -167,756 -42.16 31,457 99.64 0.1056
2020-05-18 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 397,885 397,885 15,757 0.0645
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.